Synthesis, characterization and antitumor activity of novel octahedral Pt(IV) complexes

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 8, 2003, Pages 1669-1676

  Kwon, Young Ee ^a   Whang, Kyu Ja ^b   Park, Young Ja ^b   Kim, Kuk Hwan ^c  

^a Drug Discov Inst STC Life Sci C   (South Korea)

^b Sookmyung Women's University   (South Korea)

^c Dongduk Women's University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; PLATINUM COMPLEX;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY WEIGHT; CANCER CELL CULTURE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IC 50; INFRARED RADIATION; LEUKEMIA; MELANOMA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; X RAY DIFFRACTION;

ANIMALIA;

EID: 0037379012     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(03)00044-0     Document Type: Article

References (21)

1. Rosenberg B., VanCamp L., Trosko J.E., Mansour V.H. Nature. 222:1969;385.
2. Einhorn L.H., Donohue J. Ann. Intern. Med. 87:1977;293.
3. Ozols R.F., Young R.C. Semin. Oncol. 11:1984;251.
4. Soloway M.S. J. Urol. 120:1978;716.
5. Fiorentino, M. V.; Ghiotto, C. In Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy; Nicolini, M., Ed.; Martinus Nijhoff: Boston, 1988; p 415.
6. Wagener D.J., Yap S.H., Wobbes T., Burghouts J.T., van Dam F.E., Hillen H.F., Hoogendoorn G.J., Scheerder H., van der Vegt S.G. Cancer Chemother. Pharmacol. 15:1985;86.
7. Von Hoff D.D., Schilsky R., Reichert C.M., Reddick R.L., Rozencweig M., Young R.C., Muggia F.M. Cancer Treat. Rep. 63:1979;1527.
8. Krakoff I.H. Cancer Treat. Rep. 63:1979;1523.
9. Inoue K., Mukaiyama T., Mitsui I., Ogawa M. Cancer Chemother. Pharmacol. 15:1985;208.
10. Foster B.J., Clagett-Carr K., Leyland-Jones B., Hoth D. Cancer Treat. Rev. 12(Suppl. A):1985;43.
11. Canneta R., Rozencweig M., Carter S.K. Cancer Treat. Rev. 12:1985;125.
12. Kikuchi Y., Iwano I., Miyauchi M., Kita T., Sugita M., Tenjin Y., Nagata I. Jpn. J. Cancer Res. 81:1990;701.
13. Kadhim R., al-Hussany A., Ali P.A., Hancock D.A., el-Sharkawi A.M. Ann. N. Y. Acad. Sci. 904:2000;263.
14. George C.M., Haraf D.J., Mauer A.M., Krauss S.A., Hoffman P.C., Rudin C.M., Szeto L., Vokes E.E. Invest. New Drugs. 19:2001;303.
15. Lee Y.A., Lee S.S., Kim K.M., Lee C.O., Sohn Y.S. J. Med. Chem. 43:2000;1409.
16. Ali Khan S.R., Huang S., Shamsuddin S., Inutsuka S., Whitmire K.H., Siddik Z.H., Khokhar A.R. Bioorg. Med. Chem. 8:2000;515.
17. Hagopian G.S., Mills G.B., Khokhar A.R., Bast R.C. Jr., Siddik Z.H. Clin. Cancer Res. 5:1999;655.
18. Pendyala L., Kidani Y., Perez R., Wilkes J., Bernacki R.J., Creaven P.J. Cancer Lett. 97:1995;177.
19. Kwon, Y. E.; Whang, K. J.; Kim, W. K. US Patent 6,340,770, 2002.
20. Kizu R., Nakanishi T., Yamamoto S., Hayakawa K., Matsuzawa A., Eriguchi M., Takeda Y., Akiyama N., Kidani Y. Anticancer Drugs. 9:1998;167.
21. Sheldrick, G. M. SHELXS 97 and SHELXL 97; University of Goettingen: Germany, 1997.